Bayer Settles With 30 States Over Withdrawn Drug Baycol
Main Category: Pharma Industry / Biotech IndustryAlso Included In: Litigation / Medical Malpractice; Cholesterol
Article Date: 26 Jan 2007 - 14:00 PDT
| Patient / Public: | ![]() |
5 (1 votes) |
| Healthcare Prof: | ![]() |
Thirty states on Monday reached an $8 million settlement agreement with Bayer regarding allegations that the drug company failed to adequately warn consumers about risks associated with its cholesterol-reducing drug Baycol, the AP/Winston-Salem Journal (AP/Winston-Salem Journal, 1/24). Connecticut Attorney General Richard Blumenthal (D) said the company learned after introducing Baycol in the U.S. in May 1998 that the drug posed considerably greater health risks than similar drugs, especially when taken in higher doses or in combination with another cholesterol-lowering drug. Bayer informed FDA about the drug's elevated risks but did not sufficiently warn consumers or physicians about potential problems, including a severe and potentially fatal muscle reaction that could cause kidney failure, Blumenthal said. Bayer voluntarily withdrew Baycol from the market in August 2001 (Hartford Courant, 1/24). Bayer has not admitted any wrongdoing but has agreed to register relevant clinical drug trials and study results online (AP/Winston-Salem Journal, 1/24). The company also is prohibited from making false or misleading claims in future marketing and sales of its products. The company must pay $8 million to the 30 states for future consumer protection and enforcement programs. The settlement includes Arizona, Arkansas, California, Connecticut, Delaware, Florida, Idaho, Illinois, Iowa, Kansas, Kentucky, Maine, Maryland, Massachusetts, Michigan, Mississippi, Montana, Nevada, North Carolina, Ohio, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Vermont, Virginia, Washington and Wisconsin (AP/Chicago Sun-Times, 1/24).
"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/61533.php>
APA
http://www.medicalnewstoday.com/releases/61533.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




